OSTX
Income statement / Annual
Last year (2025), OS Therapies Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, OS Therapies Inc's net income was -$28.75 M.
See OS Therapies Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$363.09 K
|
$2.78 K
|
$4.22 K
|
$805.00
|
$1.16 M
|
$4.25 K
|
| Gross Profit |
-$363.09 K
|
-$2.78 K
|
-$4.22 K
|
-$805.00
|
-$1.16 M
|
-$4.25 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$16.36 B
|
$2.84 M
|
$3.22 M
|
$3.29 M
|
$2.17 M
|
$601.78
|
| General & Administrative Expenses |
$12.34 B
|
$0.00
|
$1.12 M
|
$1.15 M
|
$1.50 M
|
$795.42
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$12.34 B
|
$3.97 M
|
$1.12 M
|
$1.15 M
|
$1.50 M
|
$795.42
|
| Other Expenses |
-$28.68 B
|
$0.00
|
$5.15 K
|
$1.21 K
|
-$0.00
|
$0.00
|
| Operating Expenses |
$28.34 M
|
$6.81 M
|
$4.34 M
|
$4.45 M
|
$3.68 M
|
$1.40 K
|
| Cost And Expenses |
$28.71 M
|
$6.81 M
|
$4.34 M
|
$4.45 M
|
$4.84 M
|
$5.65 K
|
| Interest Income |
$249.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$81.29 M
|
| Interest Expense |
$0.00
|
$2.05 M
|
$3.45 M
|
$1.81 M
|
$2.58 M
|
$461.79 M
|
| Depreciation & Amortization |
$363.09 K
|
$2.78 K
|
$4.22 K
|
$805.00
|
$805.00
|
$67.00 K
|
| EBITDA |
-$28.39 M |
-$6.83 M |
-$4.34 M |
-$4.45 M |
-$4.84 M |
$61.35 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$48.14 K
|
-$2.07 M
|
-$3.45 M
|
-$1.81 M
|
-$2.58 M
|
-$380.50
|
| Income Before Tax |
-$28.75 M
|
-$8.88 M
|
-$7.79 M
|
-$6.25 M
|
-$7.42 M
|
-$6.03 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$28.75 M
|
-$8.88 M
|
-$7.79 M
|
-$6.25 M
|
-$7.42 M
|
-$6.03 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.98 |
-0.52 |
-0.39 |
-0.28 |
-0.33 |
-0.0007 |
| EPS Diluted |
-0.98 |
-0.52 |
-0.39 |
-0.28 |
-0.33 |
-0.0007 |
| Weighted Average Shares Out |
$29.25 M
|
$20.87 M
|
$20.05 M
|
$23.10 M
|
$23.10 M
|
$8.42 M
|
| Weighted Average Shares Out Diluted |
$29.25 M
|
$20.87 M
|
$20.05 M
|
$23.10 M
|
$23.10 M
|
$8.42 M
|
| Link |
|
|
|
|
|
|
